CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-03 | Nicholson John SVP & Chief Operating Officer | Sale | −8,505 | $12.48 | $106K | 140,326 |
| 2017-02-03 | Nicholson John SVP & Chief Operating Officer | Exercise or conversion · Employee Stock Option (right to buy) | −8,505 | 45,000 | ||
| 2017-02-02 | Nicholson John SVP & Chief Operating Officer | Exercise or conversion | +66,495 | $4.65 | $309K | 206,821 |
| 2017-02-02 | Nicholson John SVP & Chief Operating Officer | Sale | −66,495 | $12.38 | $823K | 140,326 |
| 2017-02-02 | Nicholson John SVP & Chief Operating Officer | Exercise or conversion · Employee Stock Option (right to buy) | −66,495 | 53,505 | ||
| 2017-01-17 | ROBIN HOWARD W President & CEO | Exercise or conversion | +87,500 | $4.65 | $407K | 265,408 |
| 2017-01-17 | ROBIN HOWARD W President & CEO | Sale | −87,500 | $12.35 | $1.1M | 177,908 |
| 2017-01-17 | ROBIN HOWARD W President & CEO | Exercise or conversion · Stock Option | −87,500 | 87,500 | ||
| 2016-12-13 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award | +15,000 | 57,602 | ||
| 2016-12-13 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +37,500 | 37,500 | ||
| 2016-12-13 | ROBIN HOWARD W President & CEO | Grant or award | +55,000 | 177,908 | ||
| 2016-12-13 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +137,500 | 137,500 | ||
| 2016-12-13 | Nicholson John SVP & Chief Operating Officer | Grant or award | +20,000 | 140,326 | ||
| 2016-12-13 | Nicholson John SVP & Chief Operating Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2016-12-13 | Labrucherie Gil M SVP & Chief Financial Officer | Grant or award | +20,000 | 71,629 | ||
| 2016-12-13 | Labrucherie Gil M SVP & Chief Financial Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2016-12-13 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award | +15,000 | 65,843 | ||
| 2016-12-13 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award · Stock Option | +37,500 | 37,500 | ||
| 2016-12-13 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award | +20,000 | 46,479 | ||
| 2016-12-13 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 |
Page 46 of 55 · 1,088 trades